Occurrence of clinical drug interactions in prescriptions of patients suspect of adverse reaction hospitalized in the countryside of the state of Bahia, Brazil

Authors

  • Suéllyn dos Santos Gonçalves Universidade Estadual do Sudoeste da Bahia
  • Hosana Maria Santos Rodrigues Universidade Estadual do Sudoeste da Bahia
  • Inocêncio Silva de Jesus Universidade Estadual do Sudoeste da Bahia
  • Jose Ailton Oliveira Carneiro Universidade Estadual do Sudoeste da Bahia
  • Gisele da Silveira Lemos Universidade Estadual do Sudoeste da Bahia

DOI:

https://doi.org/10.13037/ras.vol14n48.3088

Keywords:

Prescriptions, drug interactions, inpatients.

Abstract

Drug interactions (DI) are a significant public health problem, and are associated with increased health care costs. The objective of this study was to evaluate the clinical occurrence of DI in patients with suspected adverse reactions in a hospital. We conducted a segment study with non-concurrent prospective follow-up of 31 medical records. In the analysis of the data was used the Micromedex® database and ICD-10 and ATC classifications. It was observed that 61.3% of patients were male with a mean age of 56±23.8 years. We analyzed 858 prescriptions andfound 1507 drug interactions. Of these, 35% were highly severe and 33% were moderately severe. From the overall DI, 53.0% were clinically observed – and 11.08% caused adverse reactions. To verify the association between the occurrence of DI and sex, age and number of drugs prescribed, it was used technical binary logistic regression and the odds ratio (OR) were calculated with confidence intervals of 95% (95% CI). By the analysis of the results, it was concluded that the amount of drugs, age and sex are directly associated with the occurrence of DI and knowing these variables can minimize damage and health risks.

 

Downloads

Download data is not yet available.

References

Rosholm JU, Bjerrum L, Hallas J, Worm J, Gram LF. Polypharmacy and the risk of drug-drug interactions among danish elderly: a prescription database study. Dan Med Bull. 1998;45(2):210-3.

Brasil. Ministério da Saúde. Secretaria de Tecnologia e Insumos Estratégicos. Departamento de Assistência Farmacêutica e Insumos Estratégicos. Formulário terapêutico nacional. Brasília: Ministério da Saúde, 2008.

Jankel CA, Speedie SM. Detecting drug interactions: a review of the literature. DICP. 1990;24(10):982-9.

Moura C, Acurcio F, Belo N. Drug-drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2009;31(5):309-16.

Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P, La Guidara C. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol. 1999;54(12):959-63.

Köhler GI, Bode-Böger SM, Busse R, Hoopmann M, Welte T, Böger RH. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther. 2000;38(11):504-13.

Gholami K, Shalviri G. Factors associated with preventability, predictability and severity of adverse drug reactions. Ann Pharmacother. 1999;33(2):236-40.

Secoli SR. Interações medicamentosas: fundamentos para a prática clínica da enfermagem. Rev Esc Enferm USP. 2001;35(1):28-34.

Nies AS. Princípios da terapêutica. In: Hardman JG, Limbird LE, editores. Goodman & Gilman: as bases farmacológicas da terapêutica. 10ª ed. Rio de Janeiro: McGraw-Hill; 2003. p. 31-44.

Domínguez A. Errores en la medicación: función del farmacêutico. Rev Farm Cuba. 2005;39(2):1-10.

Lyra Júnior DP, Kheir N, Abriata JP, Rocha CE, Santos CB, Pelá IR. Impact of pharmaceutical care interventions in the identification and resolution of drug-related problems and on quality of life in a group of elderly outpatients in Ribeirão Preto (SP), Brazil. Ther Clin Risk Manag. 2007;3(6):989-98.

Néri E. Determinação do perfil dos erros de prescrição de medicamentos em um hospital universitário [dissertação de mestrado]. Fortaleza: Universidade Federal do Ceará; 2004.

Micromedex® Healthcare Series 2.0 [base de dados na internet]. Greenwood Village: Thomson Healthcare. Atualizado periodicamente.

Organização Mundial da Saúde. CID-10: classificação estatística internacional de doenças e problemas relacionados à saúde. 9ª ed. rev. São Paulo: Edusp; 2003.

World Health Organization. Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2013. Oslo: WHO; 2012.

Malone DC, Abarca J, Hansten PD, Grizze AJ, Armstrong EP, Van Bergen RC et al. Identifications of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc. 2004;44(2):142-51.

Araujo TG, Rieder MM, Kutchak FM, Franco Filho JW. Readmissões e óbitos após a alta da UTI: um desafio da terapia intensiva. Rev Bras Ter Intensiva. 2013;25(1):32-8.

Melo DO. Avaliação das interações potenciais para pacientes internados na clínica médica do hospital universitário da USP visando à elaboração de instrumento para identificação de eventos adversos a medicamentos evitáveis [tese de doutorado]. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo; 2010.

Silva MCM, Sousa RMC, Padilha KG. Fatores associados ao óbito e à readmissão em unidade de terapia intensiva. Rev Lat Am Enfermagem. jul-ago 2011;19(4):[9telas].

Rossignoli OS, Guarido CF, Cestari IM. Ocorrência de interações medicamentosas em unidade de terapia intensiva: avaliação de prescrições médicas. Rev Bras Farm. 2006;87(4): 104-7.

Hammes JA, Pfuetzenreiter F, Silveira F, Koenig A, Westpha GA. Prevalência de potenciais interações medicamentosas droga-droga em unidades de terapia intensiva. Rev Bras Ter Intensiva. 2008;20(4):349-54.

Lima REF. Interações medicamentosas potenciais em pacientes de unidade de terapia intensiva de um hospital universitário do Ceará [dissertação de mestrado]. Ribeirão Preto: Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo; 2007.

Pincelli MP, Grumann ACB, Fernandes C, Cavalheiro AGC, Haussen DAP, Maia IS. Características de pacientes com DPOC internados em UTI de um hospital de referência para doenças respiratórias no Brasil. J Bras Pneumol. 2011;37(2):217-22.

Rama M, Viswanathan G, Acharya LD, Attur RP, Reddy PN, Raghavan SV. Assessment of drug-drug interactions among renal failure patients of nephrology ward in a south indian tertiary care hospital. Indian J Pharm Sci. 2012;74(1):63-8.

Reis AM, Cassiani SH. Adverse drug events in an intensive care unit of a university hospital. Eur J Clin Pharmacol. 2011;67(6):625-32.

Marquito AB, Fernandes NMS, Colugnatiz FAB, Paula RB. Interações medicamentosas potenciais em pacientes com doença renal crônica. J Bras Nefrol. 2014;36(1):26-34.

Devlin JW, Roberts RJ. Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids. Crit Care Clin. 2009;25(3):431-49.

Reis AMM. Fatores associados às interações medicamentosas potenciais e aos eventos adversos a medicamentos em uma unidade de terapia intensiva [tese]. Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo; 2009.

Lopez RF, Couce PM, Calvo FJ, Castro-Gaco M. Drug-induced extra-pyramidal syndrome. Q J Med. 1986;59(230):549-56.

Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med. 1996;14(5):447-50.

Locatelli J. Interações medicamentosas em idosos hospitalizados. Einstein. 2007;5(4):343-6.

Downloads

Published

2016-05-19

Issue

Vol. 14 No. 48 (2016): Revista de Atenção à Saúde

Section

ARTIGOS ORIGINAIS

License

Policy Proposal for Journals offering Free Delayed Access

 

Authors who publish in this magazine agree to the following terms:

  1. Authors maintain the copyright and grant the journal the right to the first publication, with the work simultaneously licensed under a Creative Commons Attribution License after publication, allowing the sharing of the work with recognition of the authorship of the work and initial publication in this journal.
  2. Authors are authorized to assume additional contracts separately, for non-exclusive distribution of the version of the work published in this magazine (eg, publishing in institutional repository or as a book chapter), with the acknowledgment of the authorship and initial publication in this journal.
  3. Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes, as well as increase impact and citation of the published work (See The Effect of Open Access).